A detailed history of Clayton Financial Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clayton Financial Group LLC holds 2,943 shares of ABT stock, worth $305,247. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,943
Holding current value
$305,247
% of portfolio
0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $322,317 - $355,985
2,943 New
2,943 $335 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clayton Financial Group LLC Portfolio

Follow Clayton Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Financial Group LLC with notifications on news.